Preventing infections during heart device surgery
Part of Infections clinical trials.
This study tests a special solution called taurolidine that is used during heart device surgery to help prevent infections. It might help you by reducing the risk of infection after your device is implanted or replaced.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are getting a heart device (like a pacemaker or defibrillator) implanted or replaced.
- You do not have an allergy to taurolidine (the study solution).
- You are not severely immunocompromised (for example, from chemotherapy, AIDS, or transplant medications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing an approach to improve how clinicians care for people with suspected infections around an implanted heart device (like a pacemaker or defibrillator). It may help ensure the infection is recognized and treated appropriately, especially when device removal (extraction) might be needed.
This trial looks at how to manage and check implanted heart devices (pacemakers/defibrillators) during and around a planned procedure. It may help teams improve safety and decision-making during surgery or catheter procedures.
This trial compares removing a heart device (like a pacemaker) versus using antibiotics and other medical care to treat an infection. It may help doctors decide the best way to handle infections related to these devices.
This trial tests whether a shorter course of antibiotics is as safe and effective as the standard longer course for people who have had an infected heart device removed. It aims to reduce side effects and make treatment easier.
This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.
This trial tests if a new, faster approach to replacing an infected pacemaker or defibrillator is safe. If you have a heart device infection and meet recovery milestones, you might be able to get a new device sooner than usual.
Hear when a new CIED-related Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.